TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers.

Duarte C, Bosma GN, Abbott D, Jean-Louis G, Kabat M, Stapor D, Hill B, Musoke N, Gorzewski AM, Selvakumar T, Trabolsi A, Greenberg MR, Hansen A, Bailey N, Shadman M, Kendall E, Ahmed N, Lutfi F, Johnson PC, Di M, Patel K, Bock AM, Rhodes JM, Schatz JH, Hess B, Karmali R, Frosch ZAK, Ip A, Cherng HJ, Jasem J, Bair S, Haverkos B, Kamdar M, Major A

Open source

DOI: 10.1111/ejh.70330
Published: 2026 Sep 18
Container: European journal of haematology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/ejh.70330,
  title = {TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers.},
  author = {Duarte C and Bosma GN and Abbott D and Jean-Louis G and Kabat M and Stapor D and Hill B and Musoke N and Gorzewski AM and Selvakumar T and Trabolsi A and Greenberg MR and Hansen A and Bailey N and Shadman M and Kendall E and Ahmed N and Lutfi F and Johnson PC and Di M and Patel K and Bock AM and Rhodes JM and Schatz JH and Hess B and Karmali R and Frosch ZAK and Ip A and Cherng HJ and Jasem J and Bair S and Haverkos B and Kamdar M and Major A},
  year = {2026},
  journal = {European journal of haematology},
  doi = {10.1111/ejh.70330},
  url = {https://doi.org/10.1111/ejh.70330}
}

RIS

TY  - JOUR
TI  - TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers.
AU  - Duarte C
AU  - Bosma GN
AU  - Abbott D
AU  - Jean-Louis G
AU  - Kabat M
AU  - Stapor D
AU  - Hill B
AU  - Musoke N
AU  - Gorzewski AM
AU  - Selvakumar T
AU  - Trabolsi A
AU  - Greenberg MR
AU  - Hansen A
AU  - Bailey N
AU  - Shadman M
AU  - Kendall E
AU  - Ahmed N
AU  - Lutfi F
AU  - Johnson PC
AU  - Di M
AU  - Patel K
AU  - Bock AM
AU  - Rhodes JM
AU  - Schatz JH
AU  - Hess B
AU  - Karmali R
AU  - Frosch ZAK
AU  - Ip A
AU  - Cherng HJ
AU  - Jasem J
AU  - Bair S
AU  - Haverkos B
AU  - Kamdar M
AU  - Major A
PY  - 2026
JO  - European journal of haematology
DO  - 10.1111/ejh.70330
UR  - https://doi.org/10.1111/ejh.70330
ER  -

APA

C, D., GN, B., D, A., G, J., M, K., D, S., B, H., N, M., AM, G., T, S., A, T., MR, G., A, H., N, B., M, S., E, K., N, A., F, L., PC, J., M, D., K, P., AM, B., JM, R., JH, S., B, H., R, K., ZAK, F., A, I., HJ, C., J, J., S, B., B, H., M, K., & A, M. (2026). TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers.. European journal of haematology. https://doi.org/10.1111/ejh.70330

Source records

pubmed · retrieved 2026-09-25T08:26:13.147Z